Market Tracker

11/22 2:56pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.86
BATS BZX Real-Time Price
As of 2:54pm ET
 +0.06 / +1.25%
Today’s Change
4.47
Today|||52-Week Range
8.38
-17.06%
Year-to-Date

Today’s Trading

Previous close4.80
Today’s open4.80
Day’s range4.73 - 4.89
Volume51,568
Average volume (3 months)1,606,188
Market cap$570.0M
Dividend yield--
Data as of 2:54pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+11.27%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.26+1.65%
TGTXTG Therapeutics Inc+0.05+0.68%
BYSIBeyondspring Inc-0.63-1.81%
EGRXEagle Pharmaceutical...+0.46+0.81%
Data as of 2:55pm ET, 11/22/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts